A.O. OO.RR. S.Giovanni di Dio e Ruggi d'Aragona, University of Salerno

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Acute myeloid leukaemia

Closed trials

• Completed

  (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

  NCT03580655· Phase 2· Blueprint Medicines Corporation· Source